LUX Infusion, the outpatient infusion platform backed by Frazier Healthcare Partners, has acquired Suite Health, entering Colorado, PE Hub reported. Financial terms were not disclosed in the reporting available, and neither the number of Suite Health sites nor any management rollover detail has been published.
The pattern is the established one for sponsor owned infusion care. Infusion therapy for complex chronic conditions is shifting out of hospital outpatient departments into standalone and in home settings that cost less per treatment, and platform owners grow by acquiring regional operators state by state rather than building sites organically. A Colorado entry gives LUX a new payer market and referral base in one transaction.
Frazier Healthcare Partners is a healthcare focused private equity firm, and LUX is one of its services platforms. Without disclosed terms, the deal cannot be sized against the week’s larger healthcare transactions, and this story records the ownership change and its geography only. It ships at grade C because it rests on a single trade report with no company announcement in the window.